menopausal hormone therapy


Also found in: Dictionary, Wikipedia.

menopausal hormone therapy

The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.
References in periodicals archive ?
Early studies suggested menopausal hormone therapy could lower the risk for heart disease (the number-one killer of women in the United States) in postmenopausal women.
Perimenopausal women who take menopausal hormone therapy should be aware that the doses of estrogen and progestin taken for menopausal symptoms are not adequate to provide protection against an unwanted pregnancy.
In the Fall of 2003, the National Women's Health Resource Center conducted an online survey to learn more about women's views on menopausal hormone therapy. Six hundred and forty-eight visitors completed the survey, and about 60 percent had experienced either natural or surgical menopause.
Key clinical point: Low-dose menopausal hormone therapy did not affect the progression of atherosclerosis, even when started early and continued for up to 4 years.
prescribing patterns of menopausal hormone therapy, 2001-2003." Obstet Gynecol.
Menopausal hormone therapy increases risk for breast cancer.
The Framingham study is important because it provides evidence to combat the erroneous concept that menopause accelerates heart disease, a notion that was used to pressure women into taking menopausal hormone therapy. We now know, from the Women's Health Initiative and other studies, that menopausal hormone therapy doesn't protect against heart disease (it may actually increase risk), and that it increases the risk of stroke, dementia, and pulmonary embolism (which are blood clots in the lung).
"DOES THE DISCONTINUATION OF MENOPAUSAL HORMONE THERAPY AFFECT A WOMAN'S CARDIOVASCULAR RISK?"
Postmenopausal hormone therapy, until recently referred to as "hormone replacement therapy," or "HRT," is now termed "menopausal hormone therapy" (MHT), or simply "hormone therapy" (HT).
He said that he hopes the scientific statement will lead to a new perspective on menopausal hormone therapy. "This perspective is only in younger women, and we need to consider the risks and benefits for the women who are considering its use."
Washington, June 23 (ANI): Scientists have presented a comprehensive, objective evaluation of the benefits and risks associated with menopausal hormone therapy (MHT) in the Endocrine Society Scientific Statement.